［1］GARCIA H H，DEL BRUTTO O H.Neurocysticercosis：updated concepts about an old disease［J］. Lancet Neurol,2005，4(10)：653-661.
［2］LI T，ITO A，PENGCUO R，et al.Post-treatment follow-up study of abdominal cystic echinococcosis in tibetan communities of northwest Sichuan Province，China［J］.PLoS Negl Trop Dis,2011，5(10)：e1364.
［3］TORGERSON P R，MACPHERSON C N.The socioeconomic burden of parasitic zoonoses：global trends［J］.Vet Parasitol,2011，182(1)：79-95.
［4］SCOTT J C，STEFANIAK J，PAWLOWSKI Z S，et al.Molecular genetic analysis of human cystic hydatid cases from Poland：identification of a new genotypic group(G9) of Echinococcus granulosus［J］.Parasitology，1997，114(1)：37-43.
［5］LE T H，PEARSON M S，BLAIR D，et al.Complete mitochondrial genomes confirm the distinctiveness of the horse-dog and sheep-dog strains of Echinococcus granulosus［J］.Parasitology，2002，124(1)：97-112.
［6］LAVIKAINEN A，LEHTINEN M J，MERI T，et al.Molecular genetic characterization of the Fennoscandian cervid strain，a new genotypic group(G10) of Echinococcus granulosus［J］.Parasitology，2003，127(3)：207-215.
［7］NAKAO M，MCMANUS D P，SCHANTZ P M，et al.A molecular phylogeny of the genus Echinococcus inferred from complete mitochondrial genomes［J］.Parasitology，2007，134(5)：713-722.
［8］NAKAO M，LAVIKAINEN A，YANAGIDA T，et al.Phylogenetic systematics of the genus Echinococcus (Cestoda：Taeniidae)［J］.Int J Parasitol，2013，43(12-13)：1017-1029.
［9］MCMANUS D P.Current status of the genetics and molecular taxonomy of Echinococcus species［J］.Parasitology，2013，140(13)：1617-1623.
［10］MA J Y，WANG H，LIN G H，et al.Molecular identification of Echinococcus species from eastern and southern Qinghai，China，based on the mitochondrial cox1 gene［J］. Parasitol Res，2012，111(1)：179-184.
［11］LIU Q，CAO L L，ZHANG Y G，et al.Genotypes of Echinococcus granulosus in animals from Yushu，northeastern China［J］.Vector Borne Zoonotic Dis，2013，13(2)：134-137.
［12］YAN N，NIE H M，JIANG Z R，et al.Genetic variability of Echinococcus granulosus from the Tibetan plateau inferred by mitochondrial DNA sequences［J］.Vet Parasitol，2013，196(1-2)：179-183.
［13］WANG N，WANG J H，HU D D，et al.Genetic variability of Echinococcus granulosus based on the mitochondrial 16S ribosomal RNA gene［J/OL］.Mitochondr DNA，2013.［2014-06-25］.http://informahealthcare.com/doi/abs/10.3109/19401736.2013.840590.
［14］ZHANG W，ZHANG Z，SHI B，et al.Vaccination of dogs against Echinococcus granulosus，the cause of cystic hydatid disease in humans［J］.J Infect Dis，2006，194(7)：966-974.
［15］ZHANG W，MCMANUS D P.Vaccination of dogs against Echinococcus granulosus：a means to control hydatid disease［J］.Trends Parasitol，2008，24(9)：419-424.
［16］郭宝平.犬抗细粒棘球绦虫保护性抗原EgM9重组蛋白引起免疫应答变化规律的研究［D］.乌鲁木齐：新疆农业大学，2007.
［17］PETAVY A F，HORMAECHE C，LAHMAR S，et al.An oral recombinant vaccine in dogs against Echinococcus granulosus，the causative agent of human hydatid disease：a pilot study［J］.PLoS Negl Trop Dis，2008，2(1)：e125.
［18］AL-QAOUD K M，ABDEL-HAFEZ S K.Humoral and cytokine response during protection of mice against secondary hydatidosis caused by Echinococcus granulosus［J］.Parasitol Res，2005，98(1)：54-60.
［19］高鹏，雄英，杜娟，等.细粒棘球绦虫（中国大陆株）谷胱甘肽s-转移酶重组蛋白（rEgGST）的免疫保护性研究［J］.中国人兽共患病学报，2011，27(3)：238-240.
［20］王健，师志云，赵巍.细粒棘球蚴延伸因子-1重组蛋白对小鼠的免疫保护性研究［J］.中国药房，2008，19(31)：2408-2409.
［21］LIGHTOWLERS M W，LAWRENCE S B，GAUCI C G，et al.Vaccination against hydatidosis using a defined recombinant antigen［J］.Parasite Immunol，1996，18(9)：457-462.
［22］CHOW C，GAUCI C G，COWMAN A F，et al.A gene family expressing a host-protective antigen of Echinococcus granulosus［J］.Mol Biochem Parasitol，2001，118(1)：83-88.
［23］CHOW C，GAUCI C G，COWMAN A F，et al.Echinococcus granulosus：Oncosphere-specific transcription of genes encoding a host-protective antigen［J］.Exp Parasitol，2004，106(3-4)：183-186.
［24］ZHENG H J，ZHANG W B，ZHANG L，et al.The genome of the hydatid tapeworm Echinococcus granulosus［J］.Nat Genet，2013，45(10)：1168-1175.
［25］林仁勇，丁剑冰，温浩，等.新疆株细粒棘球绦虫不同发育阶段95抗原基因克隆及序列分析［J］.中国寄生虫学与寄生虫病杂志，2003，21(3)：170-172.
［26］ZHANG W B，LI J，YOU H，et al.Echinococcus granulosus from Xinjiang PR China cDNA encoding the Eg95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere［J］.Am J Trop Med Hyg，2003，68(1)：40-43.
［27］CHOW C，GAUCI C G，VURAL G，et al.Echinococcus granulosus：variability of the host-protective EG95 vaccine antigen in G6 and G7 genotypic variants［J］.Exp Parasitol，2008，119(4)：499-505.
［28］ALVAREZ ROJAS C A，GAUCI C G，NOLAN M J，et al.Characterization of the eg95 gene family in the G6 genotype of Echinococcus granulosus［J］.Mol Biochem Parasitol，2012，183(2)：115-121.
［29］ALVAREZ ROJAS C A，GAUCI C G，LIGHTOWLERS M W.Antigenic differences between the EG95-related proteins from the G1 and G6 genotypes of Echinococcus granulosus：implications for vaccination［J］.Parasite Immunol，2013，35(2)：99-102.
［30］LIGHTOWLERS M W，JENSEN O，FERNANDEZ E，et al.Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep［J］. Int J Parasitol，1999，29(4)：531-534.
［31］HEATH D D，JENSEN O，LIGHTOWLERS M W.Progress in control of hydatidosis using vaccination-a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes［J］.Acta Trop，2003，85(2)：133-143.
［32］张壮志，石保新，张文宝，等.绵羊包虫病基因工程疫苗（Eg95）免疫试验［J］.中国人兽共患病学报，2008，24(3)：252-256.
［33］胡夏田，孙淑荣，江宇.棘球蚴基因工程疫苗免疫绵羊的保护效果观察［J］.草食家畜，2008（2）：56-58.
［34］MORARIU S，LIGHTOELERS M W，COSOROABǎ I，et al.Utilization of EG95 vaccine for sheep immunization against cystic echinococcosis in Romania［J］.Sci Parasitol，2010，11(1)：29-34.
［35］LARRIEU E，HERRERO E，MUJICA G，et al.Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro，Argentina：early impact and preliminary data［J］.Acta Trop，2013，127(2)：143-151.
［36］HEATH D D，ROBINSON C，SHAKES T，et al.Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis)［J］.Vaccine，2012，30(20)：3076-3081.
［37］HEATH D D，ROBINSON C，LIGHTOWLERS M W.Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus［J］.Vaccine，2012，30(50)：7321-7326.
［38］BARNES T S，HINDS L A，JENKINS D J，et al.Efficacy of the EG95 hydatid vaccine in a macropodid host，the tammar wallaby［J］.Parasitology，2009，136(4)：461-468.
［39］WOOLLARD D J，GAUCI C G，LIGHTOWLERS M W.Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus［J］.Vaccine，1999，18(9-10)：785-794.
［40］WOOLLARD D J，HEATH D D，LIGHTOWLERS M W.Assessment of protective immune responses against hydatid disease in sheep by immunization with synthetic peptide antigens［J］.Parasitology，2000，121(Pt2)：145-153.
［41］WOOLLARD D J，GAUCI C G，HEATH D D，et al.Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes［J］.Vaccine，2000，19(4-5)：498-507.
［42］READ A J，CASEY J L，COLEY A M，et al.Isolation of antibodies specific to a single conformation-dependant antigenic determinant on the EG95 hydatid vaccine［J］.Vaccine，2009，27(7)：1024-1031.
［43］李玉娇，王晶，赵慧，等.细粒棘球绦虫Eg95抗原表位的生物信息学预测［J］.中国人兽共患病学报，2011，27(10)：892-896，900.
［44］MA X M，ZHOU X T，ZHU Y J，et al.The prediction of T- and B-combined epitope and tertiary structure of the Eg95 antigen of Echinococcus granulosus［J］.Exp Ther Med，2013，6(3)：657-662.
［45］ESMAELIZAD M，AHMADIAN G，AQHAIYPOUR K，et al.Induction of protective T-helper 1 immune responses against Echinococcus granulosus in mice by a multi-T-cell epitope antigen based on five proteins［J］.Mem Inst Oswaldo Cruz，2013，108(4)：408-413.
［46］SCHEERLINCK J P，CASEY G，MCWATERS P，et al.The immune response to a DNA vaccine can be modulated by co-deliverry of cytokine genes using a DNA prime-protein boost strategy［J］.Vaccine，2001，19(28-29)：4053-4060.
［47］林仁勇，丁剑冰，温浩，等.全长细粒棘球蚴95抗原基因的克隆及DNA疫苗的构建［J］.新疆医科大学学报，2002，25(4)：359-361.
［48］林仁勇，丁剑冰，卢晓梅，等.细粒棘球绦虫Eg95抗原基因疫苗体外瞬时表达及对小鼠诱导的免疫应答［J］.中国寄生虫学与寄生虫病杂志，2004，22(4)：204-208.
［49］丁剑冰，魏晓丽，林仁勇，等.Eg95 基因疫苗不同免疫途径的体液免疫应答比较［J］.新疆医科大学学报，2003，26(3)：219-221.
［50］朱佑明，李文桂.细粒棘球绦虫Eg95抗原编码基因在BCG中的表达效率研究［J］.中国病原生物学杂志，2006，1(2)：95-97.
［51］李文桂，朱佑明，王鸿.细粒棘球绦虫重组BCG-Eg95疫苗免疫小鼠后IgG及其亚类和IgE的动态观察［J］.重庆医科大学学报，2007，32(1)：1-3，26.
［52］李文桂，朱佑明，王鸿.细粒棘球绦虫重组BCG-Eg95疫苗诱导小鼠脾细胞亚群变化的研究［J］.免疫学杂志，2007，23(6)：657-659.
［53］胡旭初，徐劲，陆家海，等.细粒棘球蚴Eg95全长基因的克隆与在甲醇酵母中的表达［J］.热带医学杂志，2003，3(1)：28-31，95.
［54］周必英，陈雅棠，李文桂，等.细粒棘球绦虫重组Bb-Eg95-EgA31融合基因疫苗构建及鉴定［J］.中国人兽共患病学报，2009，25(6)：502-506.
［55］周必英，陈雅棠，李文桂，等.细粒棘球绦虫重组Bb-Eg95-EgA31蛋白对感染小鼠脾细胞凋亡的抑制作用［J］.中国寄生虫学与寄生虫病杂志，2010，28(1)：26-29.
［56］周必英，李文桂.细粒棘球绦虫重组双歧杆菌-Eg95疫苗诱导小鼠抗感染的保护性免疫作用［J］.中国地方病学杂志，2012，31(6)：608-612.
［57］MARSLAND B J，TISDALL D J，HEATH D D，et al.Construction of a recombinant ORF virus that expresses an Echinococcus granulosus vaccine antigen from a novel genomic insertion site［J］.Arch Virol，2003，148(3)：555-562.
［58］TAN J L，UEDA N，HEATH D，et al.Development of orf virus as a bifunctional recombinant vaccine：surface display of Echinococcus granulosus antigen EG95 by fusion to membrane structural proteins［J］.Vaccine，2012，30(2)：398-406.
［59］DUTTON S，FLEMING S B，UEDA N，et al.Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus［J］.Parasite Immunol，2012，34(6)：312-317.
［60］叶艳菊，李文桂.细粒棘球绦虫转Eg95-EgA31融合基因苜蓿疫苗诱导小鼠免疫应答的研究［J］.细胞与分子免疫学杂志，2010，26(8)：750-753.